Biotricity, Inc. (NASDAQ:BTCY) Short Interest Update

Biotricity, Inc. (NASDAQ:BTCY) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totalling 503,000 shares, a decline of 18.7% from the May 31st total of 618,400 shares. Based on an average daily volume of 76,700 shares, the short-interest ratio is presently 6.6 days. Currently, 5.0% of the shares of the stock are sold short.

Biotricity Stock Performance

Shares of Biotricity stock traded down $0.03 on Friday, hitting $0.90. The company’s stock had a trading volume of 53,913 shares, compared to its average volume of 49,530. Biotricity has a 1 year low of $0.70 and a 1 year high of $4.06. The firm has a fifty day moving average price of $1.11 and a 200-day moving average price of $1.12. The company has a market capitalization of $8.48 million, a price-to-earnings ratio of -0.68 and a beta of 1.40.

Biotricity (NASDAQ:BTCY) last announced its quarterly earnings results on Thursday, June 27th. The company reported ($0.47) earnings per share for the quarter, missing the consensus estimate of ($0.36) by ($0.11). The company had revenue of $3.18 million during the quarter, compared to analysts’ expectations of $3.20 million. As a group, analysts forecast that Biotricity will post -0.43 EPS for the current year.

Institutional Investors Weigh In On Biotricity

An institutional investor recently bought a new position in Biotricity stock. Advisor Resource Council acquired a new position in shares of Biotricity, Inc. (NASDAQ:BTCY) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 79,070 shares of the company’s stock, valued at approximately $117,000. Advisor Resource Council owned approximately 0.84% of Biotricity at the end of the most recent quarter. Institutional investors own 3.89% of the company’s stock.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.